Alexion Announces Plans to Initiate Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19
Rankings by 
Национальный рейтинг
224th
in United StatesРегиональный рейтинг
249th
in North America and CaribbeanГлобальный рейтинг
623rd
worldwide